MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: adam hefian who wrote (658)	2/12/1998 8:02:00 PM
From: seminole	Read Replies (1) of 1826

Adam Revenues are up 40%. Sjogren approval expected very soon. They have $15 million cash and no debt. They have several potential partners for MGI 114. <<MGI 114 Partner is no where in sight,highly unlikely that there will be one>> your opinion or can you document this? <<Approval on Syjogren looks like 50/50>> Your opinion or can you document this? <<Phase 2 might never happen>> Your opinion or analysis of the phase I data? Let me give my opinion of MGI 114. I believe this drug will perform better on any cancer cell type then any drug on the market. Your opinion that it will never get to phase II is as extreme as my opinion that the FDA will beg the company to let them approve it. Lets shrink some tumors richard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next